BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2004
View Archived Issues
First phase I/II data on the efficacy and safety of HuMax-CD20 in follicular lymphoma
Read More
TLK-199 shows promise in the treatment of MDS
Read More
New phase I data on the antitumor effects and safety of talabostat
Read More
Preclinical studies support the use of AQ4N to treat lymphoproliferative diseases
Read More
Update on the pharmacokinetics of erlosamide in healthy volunteers
Read More
NFkappaB-selective estrogen receptor ligand promising against rheumatoid arthritis
Read More
Plasmin-specific inhibitor shows potent antiinvasive and antiangiogenic effects in vitro
Read More
Triad Therapeutics sells p38 kinase inhibitor program to Novartis
Read More
Specific myosin activator may be useful for treatment of heart failure
Read More
Phase II glioblastoma multiforme study for 131I-TM-601
Read More
Tapestry advances development of lead oncolytic drugs
Read More
Pilot pharmacokinetic study for zolpidem lingual spray formulation
Read More
RxGen awarded phase I of fast track SBIR grant for Parkinson's research
Read More
Enrollment completed in phase III colonoscopy study of INKP-102
Read More
New prostaglandin I2 receptor antagonists in early development at Roche
Read More
Boehringer Ingelheim scientists report agents for the treatment of hepatitis C infection
Read More
Wyeth researchers develop an antibiotic from Micromonospora
Read More
Roche patent covers novel adenosine receptor modulators for Alzheimer's, Parkinson's, etc.
Read More
New adenosine receptor antagonists and their use described in Fujisawa patent
Read More
New treatments for Parkinson's disease claimed in Schering patent
Read More
Enrollment completed in first pivotal study of milnacipran for FMS
Read More
European marketing of Alvesco to commence in 2005
Read More
Positive findings from Bentley's phase II study of intranasal insulin in diabetics
Read More
PHX-1149 scheduled to enter clinic for type 2 diabetes in 2005
Read More
Phase IIa study of PA-457 in HIV patients
Read More
FTC requests extension for review of MDX-010 collaboration
Read More
Aventis spins off Novexel
Read More
PEG-Intron available in Japan in combination with Rebetol for HCV
Read More
Teikoku Hormone and Grelan Pharmaceutical to merge
Read More